HRP20040944B1 - Medicaments containing betamimetic drugs and a novel anticholinesterase drug - Google Patents
Medicaments containing betamimetic drugs and a novel anticholinesterase drugInfo
- Publication number
- HRP20040944B1 HRP20040944B1 HRP20040944A HRP20040944B1 HR P20040944 B1 HRP20040944 B1 HR P20040944B1 HR P20040944 A HRP20040944 A HR P20040944A HR P20040944 B1 HRP20040944 B1 HR P20040944B1
- Authority
- HR
- Croatia
- Prior art keywords
- medicaments containing
- novel
- anticholinesterase drug
- betamimetic
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
The invention relates to novel medicament compositions based on long-acting beta2 agonists and salts of a novel anticholinesterase drug (I), to methods for the production of these compositions and their use in treating respiratory tract diseases.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10216428 | 2002-04-12 | ||
DE10256317A DE10256317A1 (en) | 2002-04-12 | 2002-12-03 | Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt |
PCT/EP2003/003669 WO2003087097A1 (en) | 2002-04-12 | 2003-04-09 | Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20040944A2 HRP20040944A2 (en) | 2005-04-30 |
HRP20040944B1 true HRP20040944B1 (en) | 2012-12-31 |
Family
ID=29251756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20040944 HRP20040944B1 (en) | 2002-04-12 | 2004-10-11 | Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1497289B1 (en) |
JP (1) | JP2005529111A (en) |
CN (1) | CN1646527A (en) |
AT (1) | ATE302774T1 (en) |
AU (1) | AU2003232201B2 (en) |
BR (1) | BR0309185A (en) |
CA (1) | CA2481468C (en) |
DK (1) | DK1497289T3 (en) |
ES (1) | ES2248767T3 (en) |
HR (1) | HRP20040944B1 (en) |
IL (1) | IL164291A (en) |
MX (1) | MXPA04009916A (en) |
NO (1) | NO20044107L (en) |
NZ (1) | NZ536337A (en) |
PL (1) | PL213489B1 (en) |
PT (1) | PT1497289E (en) |
RS (1) | RS50735B (en) |
UY (1) | UY27757A1 (en) |
WO (1) | WO2003087097A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20040950A1 (en) | 2003-02-14 | 2005-01-01 | Theravance Inc | BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS |
EP1577306A1 (en) * | 2004-03-17 | 2005-09-21 | Boehringer Ingelheim Pharma GmbH & Co.KG | novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases |
US7244728B2 (en) | 2004-03-17 | 2007-07-17 | Boehringer Ingelheim International Gmbh | Long acting betamimetics for the treatment of respiratory diseases |
US7745621B2 (en) | 2004-05-14 | 2010-06-29 | Boehringer Ingelheim International Gmbh | Long acting bronchodilators for the treatment of respiratory diseases |
SG159550A1 (en) | 2005-02-25 | 2010-03-30 | Chiesi Farma Spa | Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
CA2618089A1 (en) | 2005-08-08 | 2007-02-15 | Argenta Discovery Ltd. | Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
DE102005055963A1 (en) * | 2005-11-24 | 2007-07-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
DE102005055957A1 (en) * | 2005-11-24 | 2007-07-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
GB0602778D0 (en) | 2006-02-10 | 2006-03-22 | Glaxo Group Ltd | Novel compound |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
EP2662472B1 (en) | 2009-03-31 | 2019-02-27 | Boehringer Ingelheim International Gmbh | Method for coating a surface of a component |
US9265910B2 (en) | 2009-05-18 | 2016-02-23 | Boehringer Ingelheim International Gmbh | Adapter, inhalation device, and nebulizer |
EP2504052B1 (en) | 2009-11-25 | 2022-07-27 | Boehringer Ingelheim International GmbH | Nebulizer |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
JP5658268B2 (en) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Nebulizer |
EP2585151B1 (en) | 2010-06-24 | 2018-04-04 | Boehringer Ingelheim International GmbH | Nebulizer |
EP2694220B1 (en) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medical device comprising a container |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013152894A1 (en) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Atomiser with coding means |
EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
ES2836977T3 (en) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizer |
ES2954961T3 (en) | 2014-05-07 | 2023-11-27 | Boehringer Ingelheim Int | Unit, nebulizer and method |
DK3139984T3 (en) | 2014-05-07 | 2021-07-19 | Boehringer Ingelheim Int | Atomizer |
RS64124B1 (en) | 2014-05-07 | 2023-05-31 | Boehringer Ingelheim Int | Nebulizer and container |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4108393A1 (en) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS |
DE10050995A1 (en) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | New benzylic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
DE10050994A1 (en) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
-
2003
- 2003-04-09 JP JP2003584053A patent/JP2005529111A/en active Pending
- 2003-04-09 DK DK03746158T patent/DK1497289T3/en active
- 2003-04-09 CA CA2481468A patent/CA2481468C/en not_active Expired - Fee Related
- 2003-04-09 CN CNA038083302A patent/CN1646527A/en active Pending
- 2003-04-09 RS YUP-898/04A patent/RS50735B/en unknown
- 2003-04-09 MX MXPA04009916A patent/MXPA04009916A/en active IP Right Grant
- 2003-04-09 PT PT03746158T patent/PT1497289E/en unknown
- 2003-04-09 WO PCT/EP2003/003669 patent/WO2003087097A1/en active IP Right Grant
- 2003-04-09 PL PL372450A patent/PL213489B1/en not_active IP Right Cessation
- 2003-04-09 NZ NZ536337A patent/NZ536337A/en not_active IP Right Cessation
- 2003-04-09 ES ES03746158T patent/ES2248767T3/en not_active Expired - Lifetime
- 2003-04-09 BR BR0309185-6A patent/BR0309185A/en not_active Expired - Fee Related
- 2003-04-09 AU AU2003232201A patent/AU2003232201B2/en not_active Ceased
- 2003-04-09 EP EP03746158A patent/EP1497289B1/en not_active Expired - Lifetime
- 2003-04-09 AT AT03746158T patent/ATE302774T1/en active
- 2003-04-10 UY UY27757A patent/UY27757A1/en not_active Application Discontinuation
-
2004
- 2004-04-09 IL IL164291A patent/IL164291A/en not_active IP Right Cessation
- 2004-09-27 NO NO20044107A patent/NO20044107L/en not_active Application Discontinuation
- 2004-10-11 HR HR20040944 patent/HRP20040944B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1497289E (en) | 2005-11-30 |
NO20044107L (en) | 2004-11-04 |
WO2003087097A1 (en) | 2003-10-23 |
AU2003232201A1 (en) | 2003-10-27 |
UY27757A1 (en) | 2003-11-28 |
PL213489B1 (en) | 2013-03-29 |
ES2248767T3 (en) | 2006-03-16 |
IL164291A0 (en) | 2005-12-18 |
RS89804A (en) | 2006-10-27 |
CA2481468A1 (en) | 2003-10-23 |
MXPA04009916A (en) | 2005-05-03 |
PL372450A1 (en) | 2005-07-25 |
RS50735B (en) | 2010-08-31 |
NZ536337A (en) | 2007-05-31 |
CA2481468C (en) | 2011-02-01 |
HRP20040944A2 (en) | 2005-04-30 |
AU2003232201B2 (en) | 2009-06-11 |
DK1497289T3 (en) | 2005-10-24 |
BR0309185A (en) | 2005-02-15 |
JP2005529111A (en) | 2005-09-29 |
EP1497289B1 (en) | 2005-08-24 |
EP1497289A1 (en) | 2005-01-19 |
ATE302774T1 (en) | 2005-09-15 |
IL164291A (en) | 2012-04-30 |
CN1646527A (en) | 2005-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL164291A0 (en) | Medicaments containing betamimetic drugs and a novel anticholinesterase drug | |
SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
MXPA03005340A (en) | Novel medicament compositions based on anticholinesterase drugs and on ciclesonides. | |
WO2004037807A3 (en) | Medicinal arylethanolamine compounds | |
UA86977C2 (en) | Hydantoin derivatives for the treatment of obstructive airway diseases | |
GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
UA85708C2 (en) | Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases | |
WO2008022189A3 (en) | Administration of high potency platinum compound formulations by inhalation | |
HUP0402217A2 (en) | Platinum derivative pharmaceutical formulations | |
BR0009975B1 (en) | powder inhaler for a combination medicine. | |
MXPA06013221A (en) | Inhalation powder formulations containing enantiomerically pure beta-agonists. | |
YU84503A (en) | Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases | |
UA90504C2 (en) | Novel drugs for treating respiratory diseases | |
RS89904A (en) | Medicaments containing steroids and a novel anticholinesterase drug | |
PL1643999T3 (en) | Pyridoxamine for use in the treatment of diabetic neprhopathy in type ii diabetes | |
IL170519A (en) | Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them | |
MXPA04002401A (en) | Novel medicaments for inhalation. | |
MY141724A (en) | Medicaments containing betamimetic drugs and a novel anticholinesterase drug | |
BR0307703A (en) | Drug compositions based on anticholinergic agents and egfr kinase inhibitors | |
DE602004019096D1 (en) | MEDICAMENTS FOR INHALATION WITH BETAMIMETICS AND ANTICHOLINERGICUM | |
MXPA02009603A (en) | Divided dose therapies with vascular damaging activity. | |
DE50115277D1 (en) | DRUG COMPOSITIONS FROM TIOTROPIUM SALTS AND | |
DK1581224T3 (en) | Tiotropium-containing drug composition for inhalation | |
MY137679A (en) | 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders | |
UY27686A1 (en) | NEW SALTS OF CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20120327 Year of fee payment: 10 |
|
B1PR | Patent granted | ||
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20130410 |